| Nome |
# |
|
Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients, file e27ce426-f84a-2581-e053-d805fe0acbaa
|
303
|
|
Molecular markers in bladder cancer, file e27ce42f-9dfc-2581-e053-d805fe0acbaa
|
274
|
|
DKK-1 in prostate cancer diagnosis and follow up, file e27ce426-f5f9-2581-e053-d805fe0acbaa
|
250
|
|
Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer, file e27ce42d-5e50-2581-e053-d805fe0acbaa
|
171
|
|
Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: State of affairs and new frontiers, file e27ce42f-3dc3-2581-e053-d805fe0acbaa
|
154
|
|
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis, file e27ce434-7d40-2581-e053-d805fe0acbaa
|
118
|
|
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer, file e27ce42f-66a4-2581-e053-d805fe0acbaa
|
98
|
|
How to optimally manage elderly bladder cancer patients?, file e27ce42f-68e0-2581-e053-d805fe0acbaa
|
87
|
|
Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: A literature review with emphasis on the role of surgery, file e27ce42f-8a07-2581-e053-d805fe0acbaa
|
77
|
|
Adrenal ganglioneuroma with multifocal retroperitoneal extension: a challenging diagnosis., file e27ce42f-9590-2581-e053-d805fe0acbaa
|
76
|
|
Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer, file e27ce431-f344-2581-e053-d805fe0acbaa
|
75
|
|
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes, file e27ce42f-78fd-2581-e053-d805fe0acbaa
|
71
|
|
Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization, file e27ce42f-6612-2581-e053-d805fe0acbaa
|
70
|
|
Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis, file e27ce432-3a40-2581-e053-d805fe0acbaa
|
70
|
|
Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study, file e27ce42f-68de-2581-e053-d805fe0acbaa
|
63
|
|
Second line immune checkpoint inhibition in urothelial cancer, file e27ce42f-78fa-2581-e053-d805fe0acbaa
|
58
|
|
A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?, file e27ce433-a2aa-2581-e053-d805fe0acbaa
|
57
|
|
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study, file e27ce428-e5a6-2581-e053-d805fe0acbaa
|
52
|
|
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?, file e27ce432-2118-2581-e053-d805fe0acbaa
|
50
|
|
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy, file e27ce432-7df2-2581-e053-d805fe0acbaa
|
46
|
|
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis, file e27ce432-4fca-2581-e053-d805fe0acbaa
|
40
|
|
The impact of sars-cov-2 pandemic on time to primary, secondary resection and adjuvant intravesical therapy in patients with high-risk non-muscle invasive bladder cancer: A retrospective multi-institutional cohort analysis, file e27ce434-9ca7-2581-e053-d805fe0acbaa
|
35
|
|
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer, file e27ce434-5970-2581-e053-d805fe0acbaa
|
28
|
|
Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the Endourology Society (CROES)-UTUC registry, file e27ce435-2678-2581-e053-d805fe0acbaa
|
22
|
|
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al., file e27ce427-015f-2581-e053-d805fe0acbaa
|
21
|
|
Frailty impact on postoperative complications and early mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review, file e27ce433-f20f-2581-e053-d805fe0acbaa
|
17
|
|
Combination of urinary fibrinogen β-chain and tyrosine-phosphorylated proteins for the detection of bladder cancer, file e27ce434-bf18-2581-e053-d805fe0acbaa
|
17
|
|
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer, file e27ce432-4404-2581-e053-d805fe0acbaa
|
14
|
|
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis, file e27ce434-1834-2581-e053-d805fe0acbaa
|
8
|
|
A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?, file e27ce428-72ef-2581-e053-d805fe0acbaa
|
4
|
|
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors, file 41cc0a78-2ab0-49de-b7a0-fb52ffb36a03
|
3
|
|
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration, file 8da3d442-d638-4834-9b51-445a7a9cc838
|
3
|
|
Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort, file c0cfa4ce-bd94-4f04-99ee-443eb0435059
|
3
|
|
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study, file e27ce427-55e7-2581-e053-d805fe0acbaa
|
3
|
|
Hyperthermia for non-muscle invasive bladder cancer, file e27ce429-0428-2581-e053-d805fe0acbaa
|
2
|
|
Retreatment after focal therapy for failure: a bridge too far?, file e27ce42d-5e54-2581-e053-d805fe0acbaa
|
2
|
|
Intravesical bacillus Calmette-Guérin for bladder cancer: Are all the strains equal?, file e27ce42e-7f60-2581-e053-d805fe0acbaa
|
2
|
|
The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer, file e27ce42e-bc63-2581-e053-d805fe0acbaa
|
2
|
|
External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis, file e27ce42f-42e4-2581-e053-d805fe0acbaa
|
2
|
|
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?, file e27ce431-e4d2-2581-e053-d805fe0acbaa
|
2
|
|
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy, file 51e7caf5-c0b1-4817-9e6c-12204db67352
|
1
|
|
Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology – Young Academic Urologists, file 6bac9e6d-9b56-4aed-b8a8-cdbce971897d
|
1
|
|
Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients, file e27ce428-3746-2581-e053-d805fe0acbaa
|
1
|
|
Prevention of bladder cancer incidence and recurrence: Tobacco use, file e27ce42c-60fe-2581-e053-d805fe0acbaa
|
1
|
|
Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients, file e27ce42c-8b75-2581-e053-d805fe0acbaa
|
1
|
|
How to assess and improve health-related quality of life in bladder cancer patients, file e27ce42d-3c4c-2581-e053-d805fe0acbaa
|
1
|
|
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy, file e27ce42d-84fe-2581-e053-d805fe0acbaa
|
1
|
|
Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review, file e27ce42e-72f8-2581-e053-d805fe0acbaa
|
1
|
|
Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature, file e27ce42e-8950-2581-e053-d805fe0acbaa
|
1
|
|
Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer, file e27ce42f-3f35-2581-e053-d805fe0acbaa
|
1
|
|
Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma, file e27ce42f-3f37-2581-e053-d805fe0acbaa
|
1
|
|
Role of serum cholinesterase in patients treated with salvage radical prostatectomy, file e27ce42f-42d9-2581-e053-d805fe0acbaa
|
1
|
|
Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy, file e27ce42f-42e1-2581-e053-d805fe0acbaa
|
1
|
|
Prognostic Value of Serum Cholinesterase in Non–muscle-invasive Bladder Cancer, file e27ce42f-4de5-2581-e053-d805fe0acbaa
|
1
|
|
Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool, file e27ce42f-4de8-2581-e053-d805fe0acbaa
|
1
|
|
Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy, file e27ce42f-4dea-2581-e053-d805fe0acbaa
|
1
|
|
Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy, file e27ce42f-4dec-2581-e053-d805fe0acbaa
|
1
|
|
Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes, file e27ce42f-4f95-2581-e053-d805fe0acbaa
|
1
|
|
The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer, file e27ce42f-4f98-2581-e053-d805fe0acbaa
|
1
|
|
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC), file e27ce42f-4f9a-2581-e053-d805fe0acbaa
|
1
|
|
Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy, file e27ce42f-4f9d-2581-e053-d805fe0acbaa
|
1
|
|
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC), file e27ce42f-4f9f-2581-e053-d805fe0acbaa
|
1
|
|
Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non–muscle-invasive Bladder Cancer, file e27ce42f-660e-2581-e053-d805fe0acbaa
|
1
|
|
Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?, file e27ce42f-6610-2581-e053-d805fe0acbaa
|
1
|
|
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non–muscle-invasive Bladder Cancer, file e27ce42f-672b-2581-e053-d805fe0acbaa
|
1
|
|
Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy, file e27ce42f-672d-2581-e053-d805fe0acbaa
|
1
|
|
Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy, file e27ce42f-68db-2581-e053-d805fe0acbaa
|
1
|
|
The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes, file e27ce42f-68dd-2581-e053-d805fe0acbaa
|
1
|
|
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract, file e27ce42f-68e2-2581-e053-d805fe0acbaa
|
1
|
|
The surgical management of patients with clinical stage T4 bladder cancer: A single institution experience, file e27ce42f-68e4-2581-e053-d805fe0acbaa
|
1
|
|
Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 Years, file e27ce42f-68e6-2581-e053-d805fe0acbaa
|
1
|
|
Drug strategies for bladder cancer in the elderly: is there promise for the future?, file e27ce42f-6aa1-2581-e053-d805fe0acbaa
|
1
|
|
Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial, file e27ce42f-72de-2581-e053-d805fe0acbaa
|
1
|
|
Prognostic value of modified Glasgow Prognostic Score in non–muscle-invasive bladder cancer, file e27ce42f-7908-2581-e053-d805fe0acbaa
|
1
|
|
Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy, file e27ce42f-790a-2581-e053-d805fe0acbaa
|
1
|
|
Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study, file e27ce42f-8a00-2581-e053-d805fe0acbaa
|
1
|
|
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer, file e27ce42f-8a02-2581-e053-d805fe0acbaa
|
1
|
|
Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer, file e27ce42f-8a04-2581-e053-d805fe0acbaa
|
1
|
|
Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration, file e27ce42f-8b9a-2581-e053-d805fe0acbaa
|
1
|
|
Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study, file e27ce42f-a3df-2581-e053-d805fe0acbaa
|
1
|
|
The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy, file e27ce42f-d6c7-2581-e053-d805fe0acbaa
|
1
|
|
The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort, file e27ce431-0072-2581-e053-d805fe0acbaa
|
1
|
|
Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study, file e27ce431-e759-2581-e053-d805fe0acbaa
|
1
|
|
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel[Formula presented], file e27ce432-40f7-2581-e053-d805fe0acbaa
|
1
|
|
Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy, file e27ce432-4405-2581-e053-d805fe0acbaa
|
1
|
|
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis, file e27ce432-667a-2581-e053-d805fe0acbaa
|
1
|
|
Stratification of Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies, file e27ce432-667b-2581-e053-d805fe0acbaa
|
1
|
|
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration, file e27ce434-08bd-2581-e053-d805fe0acbaa
|
1
|
|
Ejaculation-sparing versus non-ejaculation-sparing anatomic GreenLight laser enucleo-vaporization of the prostate: first comparative study, file e27ce434-9636-2581-e053-d805fe0acbaa
|
1
|
|
COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral center, file e27ce435-2125-2581-e053-d805fe0acbaa
|
1
|
| Totale |
2.500 |